A Phase 1 Study to Evaluate Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants

Clinical trial NCT06345755 · COMPLETED

Trial details

NCT number: NCT06345755
Sponsor: Vertex Pharmaceuticals Incorporated
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Start date: 2024-04-17
Primary completion: 2025-01-27
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.